Mikkael A. Sekeres is director of the Leukemia Program at the Cleveland Clinic, where he is also professor of medicine and vice chair for clinical research at the Taussig Cancer Institute. He writes regularly for the Well section of the New York Times.
~~tag-text~~
Food and Drug Administration approval for COVID-19 vaccines and the controversial Alzheimer's drug Aduhelm made headlines, but few of us know much about how the agency does its work. Why is the FDA the ultimate United States authority on a drug's safety a... SEE MORE